SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-011085
Filing Date
2023-06-14
Accepted
2023-06-14 17:14:16
Documents
5
Period of Report
2023-07-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20230727xdef14a.htm DEF 14A 865361
2 GRAPHIC tmb-20230727xdef14a_a018.jpg GRAPHIC 39061
3 GRAPHIC tmb-20230727xdef14a_a019.jpg GRAPHIC 37117
4 GRAPHIC tmb-20230727xdef14a_bg001.jpg GRAPHIC 175425
5 GRAPHIC tmb-20230727xdef14a_bg002.jpg GRAPHIC 207422
  Complete submission text file 0001558370-23-011085.txt   1499221
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35182 | Film No.: 231014995
SIC: 2834 Pharmaceutical Preparations